Monopar Therapeutics Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2022 to Q2 2025
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
Monopar Therapeutics quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2022 to Q2 2025.
- Monopar Therapeutics Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2025 was 7M shares, a 99.8% increase year-over-year.
- Monopar Therapeutics annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 3.79M shares, a 37.1% increase from 2023.
- Monopar Therapeutics annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 2.76M shares, a 78.3% decline from 2022.
- Monopar Therapeutics annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 12.7M shares, a 1.98% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)